Results 11 to 20 of about 31,001 (240)

Clinical periodontal diagnosis

Periodontology 2000, EarlyView., 2023
Abstract Periodontal diseases include pathological conditions elicited by the presence of bacterial biofilms leading to a host response. In the diagnostic process, clinical signs such as bleeding on probing, development of periodontal pockets and gingival recessions, furcation involvement and presence of radiographic bone loss should be assessed prior ...
Giovanni E. Salvi, Andrea Roccuzzo, Jean‐Claude Imber, Alexandra Stähli, Björn Klinge, Niklaus P. Lang   +5 more
wiley   +1 more source

CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases

Haematologica, 2010
Background Classically, splenic marginal zone B-cell lymphoma is characterized by the absence of CD5 expression. Cases of apparent splenic marginal zone B-cell lymphoma showing CD5 expression, as diagnosed by blood studies, have been described; however ...
Lucile Baseggio, Alexandra Traverse-Glehen, Florence Petinataud, Evelyne Callet-Bauchu, Françoise Berger, Martine Ffrench, Chantal Marie Couris, Catherine Thieblemont, Dominique Morel, Bertrand Coiffier, Gilles Salles, Pascale Felman   +11 more
doaj   +1 more source

Cerebral Localized Marginal Zone Lymphoma Presenting as Hypothalamic-Pituitary Region Disorder

Case Reports in Neurology, 2011
Introduction: Marginal zone B-cell lymphoma is a rare disease which can be considerably difficult to recognize and diagnose when signs of systemic involvement are absent. Case Presentation: We report the case of a 57-year-old woman with initial olfactory
E. Broussalis, J. Kraus, A.B. Kunz, G. Luthringshausen, M. McCoy, W. Muss, G. Hutarew, G. Ladurner, E. Trinka, M. Killer-Oberpfalzer   +9 more
doaj   +1 more source

Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience [PDF]

, 2017
Rituximab is a human/murine, chimeric anti-CD20 monoclonal antibody with established efficacy, and a favorable and well-defined safety profile in patients with various CD20-expressing lymphoid malignancies, including indolent and aggressive forms of B ...
A Abulayha, A Chanan-Khan, A Davies, A Prica, AR Rezvani, B Bonavida, B Coiffier, B Coiffier, B Coiffier, B Eichhorst, B Eichhorst, BS Kahl, C Dartigeas, C Gisselbrecht, C Müller, C Taverna, CS Tam, D Daydé, D Müller, D Rossi, David G. Maloney, DG Maloney, DG Maloney, DG Maloney, DW Scott, E Bachy, E Deconinck, E Hoster, E Kimby, E Vellenga, E Zucca, EA Chong, EJ Soini, FB Hagemeister, FT Awan, G Köhler, G Lenz, G Martinelli, G Poeta Del, G Poeta Del, G Salles, G Salles, GA Salles, Gilles Salles, GJ Weiner, GJ Weiner, H Blasco, H Hochster, H Schulz, H Tilly, HC Kluin-Nelemans, HM Blommestein, HR Junlén, International CLL-IPI Working Group, J Banchereau, J Hiraga, J Hornberger, J Hornberger, J Li, JA Ray, JA Woyach, JC Byrd, JC Byrd, JM Foran, JM Vose, JO Armitage, Joerg Maurer, JP Leonard, K Fischer, K Fischer, K Fischer, K Tobinai, K Tobinai, KA Foon, KA Foon, KM Ardeshna, KM Johnston, L Li, L Tran, L Vidal, LA Torre, LD Piro, LM Nadler, M Adena, M Dreyling, M Dreyling, M Federico, M Feuring-Buske, M Hallek, M Hallek, M Herold, M Jermann, M Pfreundschuh, M Pfreundschuh, M Pfreundschuh, M Tout, MA Dimopoulos, MA Lopez-Olivo, Martin Barrett, MB Regazzi, MD Danese, ME Reff, ME Williams, MH Oers van, MH Oers van, Michael Wenger, MJ Keating, MJ Rummel, MS Czuczman, MS Czuczman, Nancy Valente, NL Berinstein, O Mandrik, OW Press, P Abrisqueta, P Boffetta, P Boross, P Colombat, P Feugier, P Hillmen, P McLaughlin, P Thompson, PV Beum, Q Chen, Q Chen, R Forstpointner, R Forstpointner, R Foà, R Griffiths, R Marcus, R Marcus, RA Miller, RI Griffiths, RI Griffiths, RL Elstrom, Robin Foà, S Assouline, S Cang, S Khor, S Maury, SG Fisher, SM Jaglowski, SM O’Brien, Susan O’Brien, T Igarashi, T Kewalramani, T Robak, TA Davis, TA Davis, TJ Kipps, TM Habermann, U Jaeger, U Jäger, UJ Mey, V Goede, V Ivanov, V Minard-Colin, V Ribrag, W Hiddemann, W Wierda, XC Badoux, Y Oki   +161 more
core   +2 more sources

Rituximab in the treatment of nodal Bcell marginal zone lymphoma, primary Sjogren’s syndrome and autoimmune hepatitis

Научно-практическая ревматология, 2008
Rituximab in the treatment of nodal B- cell marginal zone lymphoma, primary Sjogren’s syndrome and autoimmune hepatitis A case of nodal B- cell marginal zone lymphoma, primary Sjogren’s syndrome and autoimmune hepatitis treated with rituximab is ...
O A Logvinenko, VI Vasiljev, A M Kovrigina, N. V. Kokosadse, I. V. Gaiduk, B. V. Mitrikov, M. V. Maevskaya, E L Nasonov   +7 more
doaj   +1 more source

CD5-Negative Primary Mantle Cell Lymphoma Presenting with a Bilateral Conjunctival Mass: A Potential Diagnostic Pitfall

Current Oncology, 2023
Mantle cell lymphoma is a B-cell malignancy, which, in its classic form, usually involves lymph nodes and extranodal sites, and, among the extranodal sites, the gastrointestinal tract and the Waldeyer’s ring are most prevalent.
Magda Zanelli, Alberto Lugli, Andrea Palicelli, Francesca Sanguedolce, Maurizio Zizzo, Camilla Cresta, Samuele Biancafarina, Giovanni Martino, Barbara Crescenzi, Saverio Pancetti, Giuseppe Broggi, Rosario Caltabiano, Luca Cimino, Cristina Mecucci, Stefano Ascani   +14 more
doaj   +1 more source

A patient with a diagnosis of nodal marginal zone B-cell lymphoma and a t(2;14)(p24;q32) involving MYCN and IGH

Molecular Cytogenetics, 2019
Background Nodal marginal zone B-cell lymphoma is a rare entity in which the cytogenetic findings are not well defined. The t(2;14)(p24;q32) has previously been reported in three patients with blastic mantle cell lymphoma and one patient with follicular ...
Angela Brown, Isabella Sciascia-Visani, Dianna Farrell, Meg Smith, Clive Felix, Vanaja Mutharajah, Jackie Ruell, Graeme Taylor   +7 more
doaj   +1 more source

Investigating a fast-growing nodule on the face: A case of primary cutaneous marginal zone lymphoma [PDF]

Journal of Krishna Institute of Medical Sciences University, 2022
Primary cutaneous B-cell lymphomas are non-Hodgkin lymphomas that present in the skin without evidence of extracutaneous involvement at diagnosis. There are three types of primary cutaneous B-cell lymphomas: primary cutaneous marginal zone lymphoma ...
N. Ashok Kumar, Sane Roja Renuka, C. Geo Danny , Richa Jotwani   +3 more
doaj  

Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies [PDF]

, 2009
Some autoimmune conditions are associated with increased risk of lymphoid malignancies, but information on specific malignancy subtypes is limited. From the U.S.
Anderson, Lesley, Berndt, S.I., Engels, E.A., Gadalla, S., Landgren, O., Morton, L.M., Parsons, R., Pfeiffer, R., Ricker, W., Warren, J.L.   +9 more
core   +1 more source

A genome-wide association study of marginal zone lymphoma shows association to the HLA region [PDF]

, 2014
Marginal zone lymphoma (MZL) is the third most common subtype of B-cell non-Hodgkin lymphoma. Here we perform a two-stage GWAS of 1,281 MZL cases and 7,127 controls of European ancestry and identify two independent loci near BTNL2 (rs9461741, P=3.95 × 10−
Adami, H-O, Albanes, D, Ansell, SM, Armstrong, BK, Becker, N, Benavente, Y, Berndt, SI, Bertrand, KA, Birmann, BM, Boffetta, P, Bracci, PM, Brennan, P, Brooks-Wilson, AR, Burdett, L, Cerhan, JR, Chanock, SJ, Chiu, BCH, Chung, CC, Clavel, J, Conde, L, Corines, M, Cozen, W, De Bakker, PIW, De Roos, AJ, De Sanjose, S, Diver, WR, Dogan, A, Ennas, MG, Ferri, GM, Foretova, L, Fraumeni, JF, Giles, GG, Giovannucci, E, Glimelius, B, Gu, J, Habermann, TM, Hartge, P, Hjalgrim, H, Holford, TR, Holly, EA, Huang, J, Hutchinson, A, Jackson, RD, Kane, E, Kelly, RS, Kraft, P, Kricker, A, Lan, Q, Lawrence, C, Liang, L, Liebow, M, Lightfoot, T, Link, BK, Ma, B, Maria, A, Maynadie, M, Mckay, J, Melbye, M, Miligi, L, Monnereau, A, Montalvan, R, Morton, LM, Nieters, A, North, KE, Novak, AJ, Offit, K, Portlock, C, Purdue, MP, Riby, J, Ricco, R, Roman, E, Rothman, N, Severi, G, Severson, RK, Skibola, CF, Slager, SL, Smedby, KE, Smith, A, Smith, MT, Spinelli, JJ, Staines, A, Teras, LR, Thomas, T, Thompson, CA, Tinker, LF, Turner, J, Vajdic, CM, Vermeulen, RCH, Vijai, J, Villano, DJ, Vineis, P, Virtamo, J, Wang, SS, Wang, Z, Weiner, GJ, Witzig, TE, Wu, X, Ye, Y, Yeager, M, Zeleniuch-Jacquotte, A, Zhang, Y, Zheng, T   +101 more
core   +1 more source